HBR REALTY (HBRE3) Main Indicators
Basic Data - HBRE3
| Company | HBR REALTY |
| Corporate Name | HBR REALTY EMPREENDIMENTOS IMOBILIARIOS S/A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Deter patrimônio constituído por bens imóveis e direitos a eles relativos; administrar bens imóveis próprios e de terceiros; e participar. como sócia ou acionista. em outras sociedades. |
| Share | HBRE3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 5.00 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.36 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Financeiro |
| Subsector | Exploração de Imóveis |
| Segment | Exploração de Imóveis |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 09/19/2024 | |
Relative Prices - HBRE3
| Price/Earnings | 4.75 |
| Price/SBV | 0.26 |
| Price/Net Sales | 3.33 |
| Price/CFO | -1.74 |
| Price/FCF | -1.60 |
| Price/Total Assets | 0.11 |
| Price/EBIT | 1.25 |
| Price/Working Capital | 2.05 |
| Price/NCAV | -0.20 |
| EV/EBIT | 4.70 |
| EV/EBITDA | 4.67 |
| EV/Net Sales | 12.53 |
| EV/CFO | -6.55 |
| EV/FCF | -6.01 |
| EV/Total Assets | 0.40 |
| Company Market Cap | R$ 515.94 M |
| Enterprise Value | R$ 1.94 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 5.00 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 0.00% |
| Updated 09/19/2024 | |
Income Statement - HBRE3
| Net Revenue | R$ 154.87 M |
| Gross Result | R$ 123.17 M |
| EBIT | R$ 412.51 M |
| Depreciation and Amortization | - R$ 3.11 M |
| EBITDA | R$ 415.62 M |
| Net Profit | R$ 108.63 M |
| Net Profit/Share | R$ 1.05 |
| Updated 08/08/2024 | |
| Net Revenue | R$ 39.77 M |
| Gross Result | R$ 31.60 M |
| EBIT | R$ 16.59 M |
| Depreciation and Amortization | - R$ 1.12 M |
| EBITDA | R$ 17.70 M |
| Net Profit | - R$ 19.45 M |
| Profit/Share | - R$ 0.19 |
| Updated 08/08/2024 | |
Price and Volume Behavior - HBRE3
| Lowest Price 52 weeks | R$ 4.40 |
| Highest Price 52 weeks | R$ 6.87 |
| Variation 2024 | -11.97% |
| Variation 1 year | -7.41% |
| Variation 2 years(total) | 1.63% |
| Variation 2 years(yearly) | 0.81% |
| Variation 3 years(total) | -62.26% |
| Variation 3 years(yearly) | -27.69% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 1.69 M |
| Updated 09/19/2024 | |
Returns and Margins - HBRE3
| Return on Initial Tangible Capital | 6.73% |
| Return on Initial Invested Capital | 8.99% |
| Pre-Tax Return on Initial Tangible Capital | 10.19% |
| Pre-Tax Return on Initial Invested Capital | 13.62% |
| Return on Initial Shareholder´s Equity | 5.70% |
| Return on Initial Asset | 2.52% |
| Gross Margin | 79.53% |
| Net Margin | 70.14% |
| EBIT Margin | 266.35% |
| EBITDA Margin | 268.36% |
| Initial Asset Turnover | 0.04 |
| Financial Leverage | 2.40 |
| Liabilities/Net Worth | 1.40 |
| Net Debt/EBITDA | 3.43 |
| Updated 08/08/2024 | |
Balance Sheet - HBRE3
| Cash and Cash Equivalents | R$ 22.97 M |
| Total Assets | R$ 4.83 B |
| Short-Term Debt | R$ 113.47 M |
| Long-Term Debt | R$ 1.33 B |
| Gross Debt | R$ 1.45 B |
| Net Debt | R$ 1.42 B |
| Shareholder´s Equity | R$ 2.01 B |
| Share Book Value | R$ 19.49 |
| Common Shares | 103,188,981 |
| Preferred Shares | 0 |
| Total | 103,188,981 |
| Common Shares in Treasury | 287,649 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 287,649 |
| Common Shares (Except Treasury) | 102,901,332 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 102,901,332 |
| Updated 08/08/2024 | |
Cash Flow - HBRE3
| Operating Cash Flow | - R$ 296.10 M |
| Cash Flow from Investments | R$ 53.10 M |
| Financing Cash Flow | R$ 219.54 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 23.46 M |
| Updated 08/08/2024 | |
| Operating Cash Flow | - R$ 59.40 M |
| Cash Flow from Investments | R$ 18.99 M |
| Financing Cash Flow | R$ 37.73 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 2.68 M |
| Updated 08/08/2024 | |
Experimental - HBRE3
| CAPEX 3 months | - R$ 2.17 M |
| Free Cash Flow 3 months | - R$ 61.57 M |
| CAPEX 12 months | - R$ 26.55 M |
| Free Cash Flow 12 months | - R$ 322.66 M |
| Updated 08/08/2024 | |